キロミック・バイオファーマ | 10-Q：Q3 2024 四半期報告書

SEC11/09 03:54

Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in Its Deltacel-01 Clinical Trial

Businesswire10/01 20:00

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

Businesswire09/20 04:30

Kiromic BioPharma KRBP Fast Track; Galera GRTX Liquidation

BioPharmCatalyst08/15 03:36

Kiromic Stock Soars 65% on FDA Fast Track Status for Deltacel

Seeking Alpha08/15 02:50

Kiromic BioPharma's Deltacel Receives FDA Fast Track Designation

Kiromic BioPharma08/14 12:00